Author:
Witzig T.E.,Nowakowski G.S.,Habermann T.M.,Goy A.,Hernandez-Ilizaliturri F.J.,Chiappella A.,Vitolo U.,Fowler N.,Czuczman M.S.
Reference68 articles.
1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Non-Hodgkin lymphoma;Shankland;Lancet,2012
3. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues,;Swerdlow,2008
4. NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphomas. v1.2014; http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf (6 January 2014, date last accessed).
5. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial;Rummel;Lancet,2013
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献